Small amounts of ‘psychedelic’ mushrooms would be decriminalized in CT, under bill

At a time when more research is showing that the controlled ingestion of psilocybin mushrooms can help patients deal positively with depression, trauma and end-of-life issues, the state House of Representatives on Wednesday approved legislation that would decriminalize the possession of small amounts of the hallucinogenic fungi.

The bill, which opponents warned could lead to the eventual full legalization of the drug, passed 86-64 and next heads to the Senate. Thirteen Democrats voted against the bill and two Republicans voted for it.

If approved in the Senate and signed into law by the governor, the penalty for a first-time possession of a half ounce or less would be $150. State Rep. Steve Stafstrom, D-Bridgeport, co-chairman of the legislative Judiciary Committee, said that a number of patients with behavioral health issues, including substance abuse, can benefit from the use of the drug, also called “magic mushrooms” or psychedelic mushrooms. But the research, much being done at Yale University, is moving slowly because of the illegality of the drug.

Keep reading

New York’s Heavy Hand Keeps Illegal Marijuana and Tobacco Dealers in Business

While I have fond memories of life in New York, many of them involve defying some stupid rule or regulation. It’s a pleasure to now live in Arizona where government, while still idiotic, generally has a lighter touch. Unfortunately for friends and family I left behind, Empire State officialdom still hasn’t learned its lessons, as evidenced by the heavy regulatory hand stifling sort-of-legalized marijuana, and proposals to similarly reinforce the black market with an outright ban on cigarette sales.

“Governor Kathy Hochul today signed new legislation to increase civil and tax penalties for the unlicensed and illicit sale of cannabis in New York as part of the FY 2024 Budget,” the New York governor’s office announced this week. “The legislation, first proposed by the Governor in March, provides additional enforcement power to the Office of Cannabis Management and the Department of Taxation and Finance to enforce the new regulatory requirements and close stores engaged in the illegal sale of cannabis.”

Keep reading

Healthcare Non-Profit Supplies L.A. Homeless With Government-Funded Meth Pipes

Los Angeles nonprofit workers passed out boxes of government-funded crystal meth pipes to the homeless population living on Skid Row, allegedly assuming it helps prevent fatal drug overdoses.

Bodycam footage reported by local media shows workers from the Homeless Health Care Los Angeles nonprofit organization distributing the drug paraphernalia while driving around the neighborhood in a golf cart, which witnesses said only enables addicts.

“If you walk down Skid Row and see the people that are on methamphetamine … and got sores all over their body, their teeth falling out, bumps all over their face, running down the street butt naked, that’s no safety,” Tony Anthony, resident, told Fox 11 Los Angeles. “They don’t need to be coming down here passing out these glass pipes.”

The news outlet reported that the nonprofit’s executive director turned down an interview and has yet to issue a statement.

Keep reading

Ohio State receives first-ever DEA license to grow psychedelic mushrooms for research

Ohio State University is about to grow psychedelic mushrooms.

For scientific research, people.

Ohio State, alongside the mental health and wellness research and development company Inner State Inc., was awarded the first-ever license by the U.S. Drug Enforcement Agency to grow whole psilocybin mushrooms. The mushrooms will be used in the study of mental health treatment capabilities with naturally grown psychedelic mushrooms.

“This license is a major milestone not only for Inner State and Ohio State, but for the entire field of psychedelic research,” Inner State CEO Ashley Walsh said Wednesday in a news release.

The license allows Ohio State and Inner State to cultivate psilocybin mushrooms for research purposes only. All research will be conducted in a federally sanctioned and secured grow house in accordance with strict DEA regulations and guidelines.

“By combining cutting-edge techniques in genomics and metabolomics, we have the opportunity to obtain a high-resolution picture of the chemical diversity of mushrooms that have remained difficult to study for several decades,” according to Ohio State researchers Dr. Jason Slot and Dr. Kou-San Ju.

Keep reading

Magic mushroom guides in Oregon face uncertain trip ahead

In the last few weeks, dozens of students have graduated from schools in Oregon where they were trained to guide people through magic mushroom trips that can last as long as six hours. At one school, an alpaca farmer, a social worker, an ER nurse and a nutritionist were all in the same class, attempting to learn the tricks of a new trade. 

But it will be a few months until any of them can legally practice what they’ve learned in their state — and once they can, there are open questions about how the psychedelics industry will shape up there.  

“Our big mantra to students is, don’t quit your day job,” said Nathan Howard, the director of one facilitator school called InnerTrek, adding, “Yet.” 

The Oregon state government and 22 training schools are writing the rule book on the best strategy for administering a drug that has shown promise in clinical trials in combatting depression, addiction or dependencies, and anxiety around terminal illnesses.  

 he first licensed magic mushroom guides could be a model for a new sort of health care professional — but are they ready for the realities of the work and how much of a risk are the new guides taking on?  

In November 2020, Oregon voters became the first in the country to approve therapeutic use of psilocybin, which is the key ingredient in magic mushrooms. The drug became legal Jan. 1, 2023, though actual sale of the psychedelic can’t begin until the state gives its stamp of approval to laboratories which will produce the psilocybin products and service centers where they’ll be consumed. Unlike cannabis, magic mushrooms won’t be sold at dispensaries and can only be used under supervision at licensed locations. 

By state law, the supervisors or psilocybin facilitators have to be over 21, have a minimum of a high school education, and they must graduate from a training school before they take a licensing exam. Beyond that, the state entrusts school administrators to vet people through the application process and to iron out the specifics of what a day on the job might entail.  

Keep reading

Mushrooms Could Offer Improvements to Color Blindness, Study Suggests

The study on color blindness, which comes via researchers with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio, was published in Drug Science, Policy and Law.

According to Medical Xpress, the researchers behind the study “highlight some implications surrounding a single reported vision improvement self-study by a colleague and cite other previous reports, illustrating a need to understand better how these psychedelics could be used in therapeutic settings.”

Medical Xpress has more on the findings:

“In the current case, a subject with red-green CVD (mild deuteranomalia) self-administered the Ishihara Test to quantify the degree and duration of color vision improvement after using 5 g of dried psilocybin magic mushrooms. Self-reported Ishihara Test data from the subject revealed partial improvement in CVD, peaking at 8 days and persisting for at least 16 days post-psilocybin administration…Before mushroom ingestion, the subject self-administered the Ishihara Test, a series of graphics composed of a mosaic of dots varying in color, hue and size. The cards of the test are designed to hide test images from someone with color blindness that would be clearly visible to someone with color vision. For example, a graphic of red and green dots might have the number ‘3’ composed of only red dots, clearly apparent to most but invisible to the color-blind individual. During this baseline test, the subject reported scoring 14 on plates 1–21, indicating mild red-green blindness, with an additional set of four cards indicating deuteranomalia, a version of CVD that makes greens look more [like] reds. While the subject reported intensification of colors under the acute effects of psilocybin, the score showed only slight improvement to 15 at 12 hours post-administration. By 24 hours post-mushroom administration, the score reached 18, one above the cut-off of 17 required by the Ishihara Test for the classification of normal color vision. The score peaked at 19 on day eight and was still tuned into the range of normal vision four months later.” 

Findings like that have encouraged medical researchers, and forced lawmakers to reconsider longstanding prohibitions on magic mushrooms. 

Keep reading

This California Bill Would Mandate Punishment of Marijuana Debtors Without a Hearing

California’s cannabis industry, which includes state-licensed growers, manufacturers, testing companies, distributors, retailers, and event organizers, has a deadbeat problem. In a business that generated $5.3 billion in sales last year, bills for marijuana products and services frequently go unpaid, leaving creditors in the lurch and compounding the financial difficulties created by federal prohibition.

According to an estimate cited by Assembly Member Phil Ting (D–San Francisco), “the unpaid debt bubble is over $600 million across California’s supply chain.” But Ting’s solution—a bill that would inject state regulators into debt disputes between marijuana businesses—could create new problems by interfering with freedom of contract and penalizing licensees without due process.

A.B. 766, which Ting introduced in March, would require cannabis licensees to pay bills for goods or services totaling $5,000 or more within 15 days of the final date listed on the invoice. That date could be no more than 30 days after the goods were delivered or the services were performed.

When a buyer misses that state-prescribed deadline, the seller would be required to file a report with the California Department of Cannabis Control (DCC). The DCC would then be required to notify the buyer of the violation and “commence a disciplinary action,” which could lead to suspension or revocation of his license if he fails to “pay the outstanding invoice in full” within 30 days of the notice. In the meantime, the buyer would not be allowed to “purchase goods or services from another licensee on credit.”

Griffen Thorne, an attorney at the Los Angeles office of Harris Bricken, a firm that specializes in cannabis law, says the problem that Ting describes is real. But Thorne is troubled by the implications of dictating contract terms, requiring businesses to report collection issues, and imposing a penalty based on nothing more than a report, which might be based on disputed facts.

Keep reading

New York Legalized Marijuana, but a Legal Typo Is Hindering Implementation

The cannabis legalization bill that New York enacted in 2021 included a provision that was supposed to help people convicted of marijuana felonies by downgrading their records in line with current law. But a typographical error made that relief harder to obtain than legislators promised.

The section of the law dealing with prior marijuana convictions describes two situations. Paragraph 2(a)(i) refers to a person convicted of a marijuana offense that “would not have been a crime” had the 2021 changes been in effect. Paragraph 2(a)(ii) refers to a person who “would have been guilty of a lesser or potentially less onerous offense” under current law.

Paragraph 2(b) says a court that receives a petition from someone convicted of a marijuana offense that no longer exists “shall….grant the motion to vacate such conviction.” It adds that a court “may substitute, unless it is not in the interests of justice to do so, a conviction for an appropriate lesser offense” when “the petition meets the criteria in subparagraph (i) of paragraph (a).”

Whoops. That clearly should have been “the criteria in subparagraph (ii) of paragraph (a),” since it makes no sense to substitute “a conviction for an appropriate lesser offense” when no such offense exists. Because of that mistake, people with marijuana felony convictions cannot use the streamlined relief process the law was supposed to provide.

Under prior law, someone caught with eight ounces to a pound of marijuana was guilty of a felony. Under current law, possessing that amount in public is a violation punishable by a maximum fine of $250, while possessing five pounds or less at home is legal. Public possession of one to five pounds, which used to be a felony, is now a misdemeanor.

Keep reading

Lawmakers Argue that Weed Must Be Kept Illegal to Protect the Jobs of Police Dogs—Seriously

 In a stunning display of misplaced priorities, some Minnesota politicians appear to be more concerned about the jobs of drug-sniffing dogs than the lives of humans impacted by cannabis prohibition. As the push for cannabis legalization in Minnesota gains momentum, it seems the well-being of these K-9s has somehow become a primary argument against it.

Minnesota’s House of Representatives recently passed a bill to legalize non-medical marijuana for individuals 21 and older, with a vote of 71-59. However, Republican state Rep. Brian Johnson voiced his concern over the costs associated with retiring police dogs trained to sniff out cannabis. Apparently, the default state of unemployment for dogs is a problem that should hold priority over human freedom and well-being.

“I did not see anything reading through the bill dealing with our K-9 units,” Johnson said. “Can you tell me how much money is in this bill to help defer the cost to our counties and police departments for the cost of the retirement of the dogs?”

This K-9-centric mindset isn’t new. Minnesota State Sen. John Jasinski, also a Republican, previously raised the “police dog discussion” during a committee hearing, lamenting the “thousands and thousands of dollars” spent on training these furry narcs, who will now have to retire due to cannabis legalization.

It’s worth noting that the legal cannabis industry has already created hundreds of thousands of jobs for humans. Yet, it seems the careers of drug-sniffing dogs are held in higher regard by some politicians.

Keep reading

Oregon Licenses First Psilocybin Lab, But Treatment Access Remains Stalled

On April 21, Portland-based Rose City Laboratories, LLC (RCL) announced that it had been licensed by the Oregon Health Authority (OHA) to test psilocybin products for the state’s therapeutic centers. It’s the first lab to receive the required OHA license, but psilocybin treatment still can’t move forward.

In January, OHA opened its licensing applications for labs vying to test state-regulated psilocybin products, along with the manufacturers that will produce those products, the service centers where they’ll be consumed and the “trip facilitators” who will supervise the treatment sessions.

At publication time, OHA had not yet licensed any service centers. Meanwhile, only three manufacturers and four facilitators have so far received licenses. OHA is still expecting the first service centers to open their doors in 2023, but it’s not yet clear how widespread access will be at that time.

RCL will test psilocybin products for the two benchmarks of a regulated drug supply: potency and purity.

RCL began operating in 2012 and has been primarily known for testing cannabis. It began working toward psilocybin testing services in 2020, in anticipation of Measure 109—which legalized therapeutic psilocybin use at licensed service centers—being approved later that year. In January 2023, received Oregon’s first psilocybin lab accreditation, making it legally eligible for the OHA license it has now received.

Licensed manufacturers can formulate psilocybin as extracts, edibles or just the mushrooms themselves. Finished products are sent to RCL, which tests them for the two benchmarks of a regulated drug supply: potency and purity.

Keep reading